Crossmark

Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinib

Crossref DOI link: https://doi.org/10.1038/tpj.2016.83

Published Online: 2017-01-24

Published Print: 2018-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kloth, J S L

Verboom, M C

Swen, J J

van der Straaten, T

Sleijfer, S

Reyners, A K L

Steeghs, N

Gelderblom, H

Guchelaar, H J

Mathijssen, R H J
License Information

Text and Data Mining valid from 2017-01-24
More Information

Article History

Received: 30 January 2016

Revised: 17 October 2016

Accepted: 24 October 2016

First Online: 24 January 2017

Competing interests

: JJ Swen, H Gelderblom and HJ Guchelaar have an unrestricted grant from Pfizer regarding pharmacogenetic research in patients treated with sunitinib.